ArticleCancers2026

Molecular Characterization of PARP Inhibitor Response Reveals Co-Targeting Strategies in Advanced Prostate Cancer.

Bryan Correa Gonzalez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.